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Enhanced Medical Student Curriculum
By Drs. Von Samedi, Leslie Danielson, and David Czuchlewski

elcome to the second issue of the UNM PathFinder! With this newsletter, the UNM
Department of Pathology wishes to better connect with our extended family of alumni,
friends, and supporters.

The UNM Department of Pathology is on the cutting edge of education, and research, and
clinical care. We’re integrating novel, evidence-based interactive methods into our medical student teaching
activities. Our faculty are receiving awards for their teaching and research efforts. Through TriCore Reference Laboratories, we are becoming a leader in Population Health Management. Through our HTR-TASR
laboratory, translational research is flourishing. Our researchers were awarded over $22 million in research
funding in fiscal year 2015, keeping the UNM Pathology Department in the top ten pathology departments
nationwide for NIH research grant support. Our graduate students benefit from the open, collaborative
research environment in the UNM Department of Pathology and at the two national laboratories in New
Mexico, Sandia National Laboratory and Los Alamos National Laboratory.
During this season of giving, please consider a making a tax deductible gift to one of the three funds in the
UNM Department of Pathology that support education and research. Your gift today creates a legacy for
tomorrow.
Please keep in touch by sharing your news with us.

F

or the first time in more than a decade, incoming medical students at the University of New Mexico (UNM) were exposed to a renewed and enhanced curriculum in 2015. The UNM School of
Medicine is committed to provide exceptional and integrated training for the next generation of
New Mexican physicians and thus developed the enhanced curriculum. One new exciting aspect
of this curriculum was the infusion of pathology as a thread throughout their first two years. This
first half of their training was organized by organ system-specific block. However, for these eager and bright
new physicians-in-training, the introductory block was the Foundation of Medical Sciences which focused
on understanding the basic alterations associated with diseases at the molecular, cellular and histological levels. There were hands-on experiences as well for the students in laboratory setting such as seeing and touching tumors that have arisen from various tissues. The students’ enthusiasm was palpable and infectious.
The Hematology portion of the curriculum was expanded into a stand-alone course under the direction of
members of the department’s Hematopathology division. A record number of enthusiastic pathology faculty
members were in fact recruited to make this overall renewal process a reality. As with previous years, active
learning remained an essential underpinning of education as it facilitates the expansion of student knowledge and retention. This curriculum, while aligning with national trends of medical education, will ensure
that newly trained physicians will continue the rich tradition of UNM in producing doctors that provide
the highest quality care for patients. Many first year medical students praised the curriculum in their evaluations. They mentioned strengths and weaknesses. Their suggestions will help us better present the material
in the coming years. The pathology faculty members who participated should be very proud of their job
well-done. And on that note, there is always room for additional expertise and participation in the coming
blocks—come and join the fun!

Wishing you the best in the New Year!


Research Activities in Pathology: 2014–2015
By Dr. Angela Wandinger-Ness, Vice Chair for Research

I

n FY 2015, Pathology faculty received over $22 million in research funding—13.6% of the record high
HSC funding. Achievements include successful renewal of several major Centers. Dr. Wilson renewed
funding for the Spatio Temporal Modeling Systems Biology Center with subprojects and cores led by
Drs. Lidke, Wandinger-Ness, and Bearer. Dr. Willman received $1.8 million in year 10 of an NCI P30
Cancer Center award and with Pathology faculty in key leadership roles (Drs. Lidke, Sklar, Wandinger-Ness, Wheeler, Wilson) secured a 3rd consecutive 5-year renewal for UNM’s Cancer Center and was
accorded Comprehensive status effective September 2015. Dr. Wheeler received new funding for Human
Papilloma Virus research through an NCI PROSPR award, and Glaxo Smith Kline clinical trial funding that
with continuing grants totaled $5.25 million for the year. Dr. Larson closed out the 5th year of an NCATS
Clinical Translational Science Award and with Dr. Sklar leading a Drug Rescue, Repurposing and Repositioning module secured a 5-year $23 million renewal. Junior Faculty members, Drs. Gillette, Neumann and
Cleyrat received new NIH and DOD research awards. The Pathology research program held a top 10 ranking in the Blue Ridge Institute for Medical Research for the 5th consecutive year.

Douglas P. Clark, MD
Professor & The Frederick H. Harvey Chair of Pathology
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A gift today creates a legacy for tomorrow.
Make a Gift: Impact Education and Research
Why donate to support education and research at the UNM Department of Pathology?
Pathologists partner with clinicians to provide personalized medical care for each patient. Pathologists impact virtually all clinical patient care. Pathologists interpret laboratory tests with high accuracy, make “life and death” diagnoses
daily for patients and s fund. The Foucar endowment has funded research projects lead by pathology residents and
fellows and funded their travel to present their research at national conferences.
•
Contribute to the “George D. Montoya Research Scholarship Fund”. George Montoya was an exemplary
UNM Pathology staff member who dedicated his life to biomedical research. The Montoya Family and the UNM
Department of Pathology established this fund. The endowment funds annual scholarships to UNM undergraduate or
graduate students to encourage biomedical research careers.
•
Contribute to the "Dr. Thomas M. Williams & Margaret G. Williams Endowment for Education and Training"
to support the greatest educational and training needs within the Department of Pathology. Dr. Tom Williams was a
dedicated faculty member, former Chair of the UNM Pathology Department and former Executive Vice-Dean of the
UNM School of Medicine. The Williams Family and the UNM Department of Pathology established this fund.
To make a contribution, please visit our website: http://pathology.unm.edu/make-a-gift/index.html and follow the individual fund links at the bottom of the page.
Yuna Guo is the 2015
George D. Montoya
Research Scholarship
Awardee

Your generosity will impact education and training today, for better healthcare tomorrow.
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University of New Mexico Human Tissue Repository-Tissue Analysis Shared Resource
Authors: Thèrése Bocklage, MD, Medical Director, Dennis McCance, PhD, Scientific Director, and Kelly J Higgins, PhD, Senior Operations Manager and Project Consultant

OVERVIEW
Translational research has many definitions, but usually involves the facilitation of “bench-to-bedside” research activities where drugs, devices, or diagnostics are moved from the research lab into the patient care setting.
Whether it involves the translation of basic research discoveries from animal model systems to human systems, or the performance of correlative laboratory studies in clinical trials, one critical element is access to human
tissue and novel analytical platforms. The Human Tissue Repository-Tissue Analysis Shared Resource (HTR-TASR) in the Pathology Department is an important catalyst for such translational research at The University of
New Mexico.
The HTR-TASR, established in 2003, is jointly funded and managed by the Department of Pathology and the UNM Comprehensive Cancer Center. The HTR-TASR primarily collects tissues from consented UNM Health
Sciences Center patients who have surgeries performed at our hospitals. Subsequently, their high quality tissue samples are processed, stored, annotated and made available to UNM researchers with IRB approved protocols.
High specimen integrity and strict donor confidentiality characterize the samples. Current holdings include more than 22,000 specimens encompassing a wide range of cancers, often with accompanying normal tissues. The
UNM HTR-TASR recently successfully finished a five-year, multi-site study sponsored by the NCI that evaluated optimal methods for human specimen preservation. Results of this work will enable the NCI Office of Biorepositories and Biospecimen Research to further refine best practice recommendations. The UNM-HTR is proud to have participated in this nationally-led initiative.

HTR-TASR SERVICES
In addition to tissue collection, processing, and storage for research, the HTR-TASR provides a wealth of other services to UNM researchers. Innovative services recently introduced into the HTR-TASR include novel assay
development for tissue analysis using the Ventana Discovery platform for immunohistochemical and fluorescent in situ hybridization assay development. Such assays are augmented by quantitative image analysis capabilities using state-of-the-art software created by a local Corrales company. Other new services include real-time PCR, next-generation sequencing, and other molecular pathology testing conducted by an experienced research
scientist, Jin Wu, MD.

NEW VENTURES
The UNM Cancer Center has joined a consortium, called ORIEN, made up of leading Cancer Centers throughout USA. This consortium will share de-identified patient data and tissues in an effort to speed up and optimize research and clinical trials. The HTR-TASR will be the collecting site for tumor tissue at
UNM and will be an important component of the consortium and its goal of accelerating bench to bedside medicine.

FACULTY AND STAFF OF THE HTR-TASR
Nine members operate the HTR-TASR: a senior operations manager (Kelly Higgins, PhD), a senior technical manager (Cathy Martinez, PA), a research associate professor (Jin Wu, MD), two research technicians (Josh Dorrance, BA and Chrys Djatche de Kamgaing, BS), an administrative assistant (Karen Capobianco,
BA), and a systems manager (Fred Schultz, MA). Two co-directors, one scientific (Dennis McCance, PhD) and the other medical (Thèrése Bocklage, MD), round
out the group.

SUMMARY
Now in its 13th year, the HTR-TASR continues to grow and undertake new challenges all the while committed to serving UNM medical researchers and
through them, the diverse population of the Southwest.
http://pathology.unm.edu/htr-tasr/index.html
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TriCore Reference Laboratories—Changing the Way Healthcare is Delivered
Written by Khosrow R. Shotorbani MBA, MT (ASCP), Chief Executive Officer and Michael Crossey MD, PHD, Chief Medical Officer

TriCore and the University Of New Mexico Department Of Pathology began a partnership more than 17 years ago and we have both evolved since
that time. Most recently the UNM School of Medicine celebrated its 50th anniversary and, to quote Dean Roth, “(UNMSOM) is looking forward
to what we hope to achieve in the next 50 years.” TriCore also celebrates past accomplishments and is looking forward to the future.
Innovation is happening today within the Pathology Department and TriCore. TriCore is building on its core competency as a clinical laboratory
by adding three innovative business lines which will change the way healthcare is delivered. With access to 70% of New Mexico’s historical clinical laboratory data, TriCore is well-positioned to deliver valuable health information that significantly improves screening, diagnosis, and targeted
treatment, resulting in better outcomes. The three business lines leveraging New Mexico data are TriCore’s Research Institute, Diagnostic Optimization Institute, and Laboratory Management Services. The combination of being a laboratory that produces clinically actionable data and providing
analytics that can aggregate data at the patient or population level is new territory for pathologists and laboratories.
In February 2015 we opened TriCore Research Institute (TRI) which performs clinical device trials with the UNM Department of Pathology and
others in the research community. TRI supports the research community by providing the most current diagnostic laboratory techniques and translational research to further clinical advancements. With both the agility and strength to steer clinical trials through to their prompt and successful
completion, we offer personalized attention to facilitate a study, maximize resources and minimize costs.
Data is imperative to the Diagnostic Optimization Institute which was established to improve healthcare outcomes and lower healthcare costs. TriCore is building targeted intervention models based on New Mexico’s most prevalent disease states and can push data to providers and care managers in real time to potentially change health outcomes.
Last, but not least, TriCore is offering Laboratory Management Services to other health systems to improve processes and efficiencies. Through these
new partnerships, we will share our expertise and quality management system (TriCore is accredited to the ISO15189 International Standard for
Medical Laboratories by the CAP 15189SM program).
We’re excited to share this great news with our colleagues at the Department of Pathology.
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Open and Collaborative Research:
Key to M. Frank Erasmus’ Success

“Open” describes M. Frank Erasmus, in personality and in professional pursuits. Frank is a dynamic,
goal driven, and externally funded graduate student
in the UNM SOM Biomedical Sciences Graduate
Program. Frank exudes enthusiasm for the open,
collaborative, intellectual environment in New
Mexico, created by research scientists at the UNM
School of Medicine’s Department of Pathology, the
UNM Comprehensive Cancer Center, the UNM
Center for Advanced Research Computing, The
UNM Center for Molecular Discovery, Los Alamos
National Laboratory and Sandia National Laboratory. Mr. Erasmus has visions of translational
research, future cancer cures and the multifaceted
resume to propel his career forward.

Written by Barbara Griffith, MS

After attaining his BS degree in Molecular Biology
from California Polytechnic State University in San
Luis Obispo, California, Frank gained insightful
industry experience at Medtronic Inc. in Minneapolis, MN and at Newport Scientific Inc. in Irvine,
CA. He achieved an
MS degree in the
Frank sees the University of New Mexico’s School
molecular biology
and structural bioof Medicine as gaining prestige and as attractive for
chemistry program
new professionals seeking an open, collaborative,
at San Diego State
and scientifically diverse environment.
University. Frank was
intrigued by the new
antibody approaches
to cancer treatment.
So why did Frank choose graduate training in the
Department of Pathology at the University of New
Mexico School of Medicine?
Frank was attracted to the integrated network of
theoretical and biological scientists associated with
the New Mexico Center for the Spatiotemporal
Modeling of Cell Signaling (STMC), headed by
Dr. Bridget Wilson. The STMC opened pathways
for Frank to work with Dr. Bridget Wilson, a cell
biologist in the UNM Department of Pathology, Dr.
Stuart Winter, an oncologist in the UNM Department of Pediatrics, Dr. Diane Lidke, a biophysicist
in the UNM Department of Pathology, and Dr.
Gnanakaran, a computational chemist at Los Alamos National Laboratory (LANL). What an amazing
team of mentors for Frank’s translational research
project! Frank is able to work at least 3 days per
week at UNM and 2 days per week at LANL. This
intellectually rich team of mentors works openly
and collaboratively, in a way that Frank had not
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seen before.
Frank Erasmus currently studies tonic signaling
by the pre-BCR in acute lymphoblastic leukemia
(ALL) to lead to new antibody therapies in this
childhood and adult malignancy. Frank’s doctoral
project revolves around characterizing the pre-BCR
pathway, developing antibody treatments, and
characterizing ligands presented to leukemia cells
by the microenvironment of the bone marrow. The
team of researchers have a provisional patent on
ALL antibody treatment. They hope that antibody
treatments will be less toxic than current therapies
and have improved success in high risk ALL relapse
cases. When Frank completes his doctoral degree,
he plans to return to industry to develop antibodies
and possibly other drugs for combination treatment
in cancer patients. Moving antibodies and drugs
more quickly into clinical trials is one of Frank
Erasmus’ goals.
To support his doctoral pursuits, Frank successfully
competed in 2014 for a Ruth L. Kirschstein National Research Service Award (NRSA) Individual
Pre-doctoral Fellowship (Parent F31), which is a
prestigious pre-doctoral award from the National
Cancer Institute. An entrepreneur at heart, Frank
also recently won a “90 second” pitch contest
sponsored by the UNM Science & Technology
Corporation (STC) and judged by a group of New
Mexican entrepreneurs. Frank’s multidisciplinary
background in molecular biology, biochemistry,
analytical chemistry bioinformatics and computer
programming have been essential to his success.
Frank Erasmus desires to stay in New Mexico, as
M. Frank Erasmus PhD. Originally from Orange
County, CA, Frank spent time as a youth in Albuquerque NM. Frank’s father is a neurosurgeon at
Presbyterian Hospital in Albuquerque and Frank’s
fiancé works in the art world of Santa Fe. His
fiancé collaborates with the STMC to host the Art
and Science symposium in Santa Fe each spring. Art
meets science—what a great visual combination!
Frank sees the University of New Mexico’s School
of Medicine as gaining prestige and as an attractive location for new professionals who seek
an open, collaborative, and scientifically diverse
environment. The UNM Department of Pathology
is pleased to attract graduate students like Frank
Erasmus.
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Graduate Student and Post-Doctoral Fellow News
The faculty in the UNM Department of Pathology are excited to be mentors to an excellent cadre of graduate students and post-doctoral fellows. These insightful, dedicated trainees add depth to the research programs, stimulate productivity in each faculty’s laboratory and achieve their own awards.

GRADUATE STUDENT AWARDS
MR. EMANUEL SALAZAR CAVAZOS, a graduate student in Dr. Diane Lidke’s laboratory received
a Scholarship from the Mexico Secretariat of Public
Education.
MR. M. FRANK ERASMUS, a graduate student
in Dr. Bridget Wilson’s laboratory, received an F31
pre-doctoral award from the National Cancer Institute in 2015.
MS. YUNA GUO, PHD, a graduate student in Dr.
Angela Wandinger-Ness’ lab, received the UNM
Department of Pathology’s George D. Montoya
Research Scholarship in May 2015.
MS. DOMINIQUE PEREZ, a graduate student in
Drs. Alexandre Chigaev and Dr. Larry Sklar’s laboratory, is supported by Oxnard Foundation award
“Unbiased screening to identify novel therapeutics
for pediatric ALL” (Prof. Larry A. Sklar PI, November 2, 2013- May 11, 2016).
MS. CHELSEA SAITO-REIS, a graduate student in
Dr. Jennifer Gillette’s laboratory, was appointed as
a fellow on the Cardiovascular Physiology Program
T-32 in June 2015. Ms. Saito-Reis also received a
UNM Office of Graduate Studies Travel Award to
present her research at the 8th International Meeting on Membrane Scaffolds held in June 2015.
Finally, Saito-Reis’ work was selected for an oral
presentation at the American Society for Cell Biology annual meeting in December 2015.
MS. CHRISTINA TERMINI, a graduate student in
Dr. Jennifer Gillette’s laboratory, received an F31
Diversity Pre-Doctoral Fellowship from the National Heart, Lung, Blood Institute in December of
2014. Additionally, Ms. Termini defended her MS
in Music at UNM and graduated from the Department of Music with Honors in May 2015. Finally,
Ms. Termini received a number of awards this past

summer including an STMC travel award to give
an oral and poster presentation at the 8th International Meeting on Membrane Scaffolds held in June
2015. Termini also received the UNM Parent Association Scholarship, the Hispanic Woman Scholarship, and the La Crenza de la Rosa Fellowship.

POST-DOCTORAL FELLOW NEWS
YUNA GUO, PHD, completed her doctoral defense
in Dr. Angela Wandinger-Ness’ lab in the Fall of
2015 and accepted a post-doctoral position at the
Fred Hutchinson Cancer Research Center beginning in January 2016.
STEPHANIE JERMAN, PHD, formerly a graduate
student in Dr. Angela Wandinger-Ness’ laboratory,
completed her F31 funded project from the National Institute of Dental and Craniofacial Research
(NIDCR) in February 2015, completed her doctoral
defense, and moved to a post-doctoral fellowship at
Yale University.
KIMBERLY KANIGEL, PHD, formerly a graduate
student who was co-mentored in Dr. Bridget Wilson’s Laboratory, completed her doctoral defense
and moved to a post-doctoral fellowship at the
University of Colorado.
KRISTOPHER MARJON, PHD, post-doctoral
fellow in Dr. Jennifer Gillette’s laboratory, accepted
a fellowship at the Stanford University Institute
of Stem Cell Biology and Regenerative Medicine
in March 2015. He is working in the laboratory
of Irving Weissman focused on leukemia stem cell
development.
TESS SHIDELER, PHD, a post-doctoral fellow in
Dr. Wandinger-Ness’ laboratory, was selected as a
participant in the 9th annual International qBio
Summer School and Conference in July 2015. In
September 2015, Dr. Shideler was also appointed
as an Academic Science Education and Research
Training (ASERT) and Institutional Research and
PathFinder Winter 2015
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Academic Career Development Award (IRACDA)
K12 fellow (a National Institute of General Medical Sciences, NIGMS, training award).
Graduate students and their primary mentors:
M. Frank Erasmus: Bridget Wilson
Matthew Graus: Aaron Neumann
Yuna Guo: Angela Wandinger-Ness
Ellen Hatch: Diane Lidke
Dominique Perez: Alex Chigaev
Chelsea Saito-Reis: Jennifer Gillette
Emanuel Salazar Cavazos: Diane Lidke
Samantha Schwartz: Diane Lidke
Rina Sylejmani : Aaron Neumann
Christina Termini: Jennifer Gillette
Congratulations to all of these trainees and their
mentors!


Faculty News
NEW FACULTY
KAREN CLINE-PARHAMOVICH, DO, Assistant
Chief Medical Investigator
ELIZABETH JOHNSON, MS, Lecturer II
AARON PRITCHARD, MD, Clinical Assistant
Professor

BARBARA MASTEN, PHD received the UNM
School of Medicine Curricular Leadership Award
MARA STEINKAMP, PHD was a member of the
qbio summer school teaching faculty for Systems
Biology and Modeling.
BRIDGET WILSON. PHD hosted the National
Systems Biology Center Meeting in Albuquerque,
NM July 9–10, 2015.

NEW BOOKS
DR. MOHAMMAD VASEF published “Diagnostic Pathology: Molecular Oncology.” Dr. Vasef
worked closely with UNM Pathology Drs. David Czuchlewski, Therese Bocklage, and Devon
Chabot-Richards to recently publish this new text
book. The new book is a guide for practicing pathologists, pathology residents, and fellows to keep
up with the rapidly evolving practice of pathology
in the era of personalized medicine. Additional
UNM contributing authors include Drs. J. Hanson,
R. Bakkar, M. Barry, E. Fischer, N. Joste, L. Lomo,
S. Reynolds, V. Samedi, K. SantaCruz, E. Loo, D.
Cherukuri, A. Mahmoud, R. Gullapalli, Q. Zhang,
C. Wilson, K. Foucar.

Faculty Appearances
Upcoming national and international talks by our
faculty.

VEENA SINGH, MD, MPH, Medical Investigator

AWARDS, RECOGNITION

Dr. Rania Bakkar
•

LESLIE DANIELSON, PHD received the UNM
School of Medicine Educational Leadership Award
JENNIFER GILLETTE, PHD received the UNM
SOM Apple for Teacher Award 2015 for Biomedical Research Education Program and UNM HSC
Excellence in Research Junior Faculty Award. Dr.
Gillette was selected based on her work in publications, research funding, novelty and creativity,
and contributions to her field. Dr. Gillette was
recognized for her work in Leukemia and Stem Cell
Therapies, and for her dedication to mentoring the
next generation of Stem Cell Biologists.

January 14–15, 2016: “Biomarkers in Breast
Pathology” at the Breast Gynecological International Cancer Conference, Cairo, Egypt.

Dr. Elaine Bearer
•

January 28–29, 2016: Bank of America-Giannini Foundation Colloquium, Stanford University,
Stanford, CA

Dr. Tione Buranda
•

February 14–19, 2016: Invited speaker in
“Inflammation and Infection” session, Gordon
Conference, Ventura, CA
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Faculty Appearances continued

Dr. Diane Lidke

Have Alumni News?

Dr. Douglas Clark

•

February 1, 2016: Invited seminar, Charles
Easton Seminars Series, Department of Immunology, University of Toronto, “Imaging Mast
Cell Activation: from Single Molecules to Synapses”, Toronto, Canada

•

February 27, 2016: Invited talk at the 2016
Biophysical Society meeting “Imaging the early
events in membrane receptor signaling”, Los
Angeles, CA

The Department of Pathology is keenly interested
in you, your accomplishments and your life’s landmarks. Have children or grandchildren enriched
your lives? Do you have personal achievements
that you wish to share with your fellow alumni
(e.g. running a marathon, writing a book, leading
a community project, and more)? Have you received professional honors or attained professional
goals(e.g. awards from national professional societies, seminal articles or book chapters published
in your field, promotions or tenure, and more) that
you wish to share? Please email your news, photos,
and contact information to bgriffit@salud.unm.edu
and wfcollins@salud.unm.edu. Your news will be
included in a future UNM Pathology PathFinder
newsletter. Thank you in advance, for contributing
your news.

•

June 5–9, 2016: 28th Annual Advances in Cytology Course, Harvard Medical School, Boston, MA.

Dr. David Czuchlewski
•

March, 2016: “Bone Marrow Manifestations of
Systemic Disease.” Educational course with Dr.
George, United States and Canadian Academy
of Pathology Annual Meeting, Seattle, WA

Dr. Kathy Foucar
•

•

•

January 28, 2016: “B and T Cell Chronic
Lymphoproliferative Disorders”, “Acute myeloid leukemia” and Case presentations, Weill
Cornell Department of Pathology’s Annual
Neoplastic Hematopathology Course, New
Orleans, LA
February 7–12, 2016: Snowmass, Five lectures
on Myeloid and Lymphoid Disorders, 37th
Annual Seminar Pathology Review Symposium,
Aspen, CO
June 27–30, 2016: Faculty lecturer for a 4 day
Scientific Symposium course on Hematopathology, Greensboro, GA

Dr. Tracy George
•

•

•

March, 2016: “Bone Marrow Manifestations
of Systemic Disease.” Educational course with
Dr. Czuchlewski, United States and Canadian
Academy of Pathology Annual Meeting, Seattle,
WA
April 2, 2016: “The Diagnosis, Classification
and Clinical Care of MDS.” at the 6th Emirates
Hematology Conference with the American Society of Clinical Pathology, Dubai, United Arab
Emirates
May 14, 2016: “From Bench to Bedside: Advances in Mastocytosis.” International Society
of Laboratory Hematology Annual Meeting,
Milano, Italy

Dr. Kurt Nolte
•

January 21, 2016: Inaugural Dr. Robert Brissie Memorial Lecture at the University of
Alabama-Birmingham. The talk is “Advanced
Radiological Imaging and the Transformation
of Forensic Pathology.” Birmingham, AL

•

February 23, 2016: “Advanced Radiological
Imaging and the Transformation of Forensic Pathology” at the Interdisciplinary Symposium on
Technology Innovation and Adoption in Forensic Sciences at the American Academy of Forensic Sciences annual meeting in Las Vegas, NV

Dr. Larry Sklar
•

February 10, 2016: Keynote speaker at FlowTex Cytometry Conference 2016 at the Onstead Auditorium at the Texas Medical Center
in Houston, TX
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Please share your comments, suggestions, and
questions with:


Alumni News

William F. Collins: wfcollins@salud.unm.edu

In 2012, CARMEN FRIAS-KLETECKA, MD
(Molecular Genetics Fellow 2010–11; Surgical
Pathology Fellow 2011–12) was recruited by The
Louisiana State University Health Sciences Center
(LSU HSC) in New Orleans to be medical director
of the molecular laboratory and establish critical
molecular tests. The LSU HSC Molecular Laboratory recently moved into the new hospital built to
replace Charity hospital, which was damaged by
Hurricane Katrina in 2005. Dr. Frias-Kletecka and
her husband were married in 2002 while they were
both students at the University of New Mexico.
They have two children; Stone, 12, and Xochitl, 7.
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Barbara B. Griffith: bgriffit@salud.unm.edu
We look forward to your feedback.
For more information on our department,
please visit our website:
http://pathology.unm.edu
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